We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBNY
126
DELISTED
Signature Bank
SBNY
| $31M | 0.07% |
218,550
-22,927
| -9% | -$3.46M |
|
127
DuPont de Nemours
DD
$19.2B
| $30.7M | 0.07% |
190,497
-22,387
| -11% | -$4.05M |
|
|
PRAH
128
DELISTED
PRA Health Sciences, Inc.
PRAH
| $30.5M | 0.06% |
368,184
-13,329
| -3% | -$1.18M |
|
129
Healthcare Services Group
HCSG
$1.53B
| $30.4M | 0.06% |
699,909
+91,333
| +15% | +$4.47M |
|
130
Icon
ICLR
$12.7B
| $30.4M | 0.06% |
257,091
-32,994
| -11% | -$3.78M |
|
131
Mercury Systems
MRCY
$6.52B
| $30.4M | 0.06% |
628,497
-19,067
| -3% | -$909K |
|
132
Teladoc Health
TDOC
$1.3B
| $30.4M | 0.06% |
753,248
-26,670
| -3% | -$1.01M |
|
|
INXN
133
DELISTED
Interxion Holding N.V.
INXN
| $30M | 0.06% |
483,003
-16,798
| -3% | -$1M |
|
134
Merit Medical Systems
MMSI
$5.32B
| $29.9M | 0.06% |
659,382
-19,718
| -3% | -$893K |
|
135
Protolabs
PRLB
$2.13B
| $29.9M | 0.06% |
254,176
-8,970
| -3% | -$1.01M |
|
136
Prosperity Bancshares
PB
$8.89B
| $29.5M | 0.06% |
406,234
-36,952
| -8% | -$2.77M |
|
|
APC
137
DELISTED
Anadarko Petroleum
APC
| $29.4M | 0.06% |
486,663
-347,053
| -42% | -$20.3M |
|
138
Bread Financial
BFH
$4.38B
| $29.4M | 0.06% |
172,797
-27,984
| -14% | -$5.47M |
|
139
Marathon Petroleum
MPC
$83.7B
| $29.3M | 0.06% |
400,734
-101,568
| -20% | -$6.99M |
|
140
Generac Holdings
GNRC
$12.5B
| $29.2M | 0.06% |
636,732
-19,388
| -3% | -$922K |
|
141
RingCentral
RNG
$5.28B
| $29M | 0.06% |
456,140
-69,729
| -13% | -$4.08M |
|
|
CY
142
DELISTED
Cypress Semiconductor
CY
| $28.7M | 0.06% |
1,694,114
+403,637
| +31% | +$6.92M |
|
|
ENV
143
DELISTED
ENVESTNET, INC.
ENV
| $28.7M | 0.06% |
500,024
-16,007
| -3% | -$880K |
|
|
CTLT
144
DELISTED
CATALENT, INC.
CTLT
| $28.5M | 0.06% |
695,111
-87,598
| -11% | -$3.73M |
|
|
WNS
145
DELISTED
WNS Holdings
WNS
| $28.2M | 0.06% |
622,040
-20,371
| -3% | -$894K |
|
|
CZR
146
DELISTED
Caesars Entertainment Corporation
CZR
| $27.8M | 0.06% |
2,472,361
-221,954
| -8% | -$2.85M |
|
|
MIME
147
DELISTED
Mimecast Limited
MIME
| $27.5M | 0.06% |
776,317
-26,846
| -3% | -$912K |
|
148
Popular Inc
BPOP
$11.1B
| $27M | 0.06% |
647,832
-116,617
| -15% | -$4.78M |
|
149
Pool Corp
POOL
$7.5B
| $26.8M | 0.06% |
183,130
-6,174
| -3% | -$850K |
|
150
Post Holdings
POST
$3.57B
| $26.7M | 0.06% |
539,408
-48,473
| -8% | -$2.45M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.